Literature DB >> 1124317

Digoxin concentrations in serum and saliva.

W J Jusko, L Gerbracht, L H Golden, J R Koup.   

Abstract

Serum and mixed saliva concentrations of digoxin were measured in 34 hospitalized patients. The mean saliva:serum concentration ratio of digoxin was 1.14 (plus or minus 0.48). Of 20 patients with saliva digoxin concentrations in the range of 0.7 to 1.5 ng/ml, 18 patients had serum concentrations which were within the same range. Saliva offers a convenient and noninvasive means of monitoring the digoxin status of patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1124317

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  7 in total

Review 1.  Therapeutic drug monitoring in saliva. An update.

Authors:  R K Drobitch; C K Svensson
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

2.  Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.

Authors:  C J van Boxtel; J T Wilson; S Lindgren; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

Review 3.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

4.  A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants.

Authors:  Laura Hutchinson; Marlene Sinclair; Bernadette Reid; Kathryn Burnett; Bridgeen Callan
Journal:  Br J Clin Pharmacol       Date:  2018-03-25       Impact factor: 4.335

Review 5.  Drug level monitoring in paediatric practice.

Authors:  G W Rylance; T A Moreland
Journal:  Arch Dis Child       Date:  1980-02       Impact factor: 3.791

6.  Digoxin concentration in saliva and plasma in infants, children, and adolescents with heart disease.

Authors:  Eli Zalzstein; Nili Zucker; Matityhau Lifshitz
Journal:  Curr Ther Res Clin Exp       Date:  2003-11

Review 7.  Revolutionizing Therapeutic Drug Monitoring with the Use of Interstitial Fluid and Microneedles Technology.

Authors:  Tony K L Kiang; Sahan A Ranamukhaarachchi; Mary H H Ensom
Journal:  Pharmaceutics       Date:  2017-10-11       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.